Aclarion, Inc. has released its Q3 2023 10-Q report, detailing significant revenue growth primarily from the UK market and strategic business developments. The report highlights increased revenue to $18,942, an improved gross profit, and a net loss of $(1,706,294) due to expanded sales and marketing efforts. The company anticipates continued revenue growth and increased R&amp;D expenses as it expands its insurance payor base and CLARITY Trial enrollment.

ACON

<p>Aclarion, Inc. 發佈了其 2023 年第三季度 10-Q 報告，詳細説明了主要來自英國市場的顯著收入增長和戰略業務發展。報告強調收入增加至 18,942 美元，毛利潤改善，淨虧損為 (1,706,294) 美元，原因是銷售和市場推廣力度的擴大。公司預計隨着保險支付方基礎和 CLARITY 試驗入組的擴展，收入將持續增長，研發費用也將增加</p>

Aclarion 公司 SEC 10-Q 季度報告